These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31897470)

  • 1. Interrelationship between Alzheimer's disease and cardiac dysfunction: the brain-heart continuum?
    Yang M; Li C; Zhang Y; Ren J
    Acta Biochim Biophys Sin (Shanghai); 2020 Jan; 52(1):1-8. PubMed ID: 31897470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alzheimer's dementia: pathogenesis and impact of cardiovascular risk factors on cognitive decline.
    Wanleenuwat P; Iwanowski P; Kozubski W
    Postgrad Med; 2019 Sep; 131(7):415-422. PubMed ID: 31424301
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Familial Presenilin Mutations and Sporadic Alzheimer's Disease Pathology: Is the Assumption of Biochemical Equivalence Justified?
    Roher AE; Maarouf CL; Kokjohn TA
    J Alzheimers Dis; 2016; 50(3):645-58. PubMed ID: 26757189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aβ Amyloid Pathology Affects the Hearts of Patients With Alzheimer's Disease: Mind the Heart.
    Troncone L; Luciani M; Coggins M; Wilker EH; Ho CY; Codispoti KE; Frosch MP; Kayed R; Del Monte F
    J Am Coll Cardiol; 2016 Dec; 68(22):2395-2407. PubMed ID: 27908343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Alzheimer's Disease Amyloid-Beta Hypothesis in Cardiovascular Aging and Disease: JACC Focus Seminar.
    Stakos DA; Stamatelopoulos K; Bampatsias D; Sachse M; Zormpas E; Vlachogiannis NI; Tual-Chalot S; Stellos K
    J Am Coll Cardiol; 2020 Mar; 75(8):952-967. PubMed ID: 32130931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term central pathology and cognitive impairment are exacerbated in a mixed model of Alzheimer's disease and type 2 diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Galindo-Gonzalez L; Garcia-Alloza M
    Psychoneuroendocrinology; 2016 Mar; 65():15-25. PubMed ID: 26708068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head injury and dementia.
    Jellinger KA
    Curr Opin Neurol; 2004 Dec; 17(6):719-23. PubMed ID: 15542981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time sequence of oxidative stress in the brain from transgenic mouse models of Alzheimer's disease related to the amyloid-β cascade.
    Belkacemi A; Ramassamy C
    Free Radic Biol Med; 2012 Feb; 52(3):593-600. PubMed ID: 22172527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac disorders as risk factors for Alzheimer's disease.
    de Toledo Ferraz Alves TC; Ferreira LK; Wajngarten M; Busatto GF
    J Alzheimers Dis; 2010; 20(3):749-63. PubMed ID: 20413875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relationship between atrial fibrillation and other cardiovascular risk factors in Alzheimer's disease. New prevention opportunities].
    Bellomo A; Mancinella M; Troisi G; Marigliano V
    Recenti Prog Med; 2009 Mar; 100(3):124-6. PubMed ID: 19475838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Soluble and insoluble protein aggregates, endoplasmic reticulum stress, and vascular dysfunction in Alzheimer's disease and cardiovascular diseases.
    Waigi EW; Webb RC; Moss MA; Uline MJ; McCarthy CG; Wenceslau CF
    Geroscience; 2023 Jun; 45(3):1411-1438. PubMed ID: 36823398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.
    Steiner H; Capell A; Leimer U; Haass C
    Eur Arch Psychiatry Clin Neurosci; 1999; 249(6):266-70. PubMed ID: 10653281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intensive 'Brain Training' Intervention Fails to Reduce Amyloid Pathologies or Cognitive Deficits in Transgenic Mouse Models of Alzheimer's Disease.
    Anderson M; Xu F; Ou-Yang MH; Davis J; Van Nostrand WE; Robinson JK
    J Alzheimers Dis; 2017; 55(3):1109-1121. PubMed ID: 27767989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presenilins and Alzheimer's disease: biological functions and pathogenic mechanisms.
    Czech C; Tremp G; Pradier L
    Prog Neurobiol; 2000 Mar; 60(4):363-84. PubMed ID: 10670705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of accelerated senescence on learning and memory, locomotion and anxiety-like behavior in APP/PS1 mouse model of Alzheimer's disease.
    Lok K; Zhao H; Zhang C; He N; Shen H; Wang Z; Zhao W; Yin M
    J Neurol Sci; 2013 Dec; 335(1-2):145-54. PubMed ID: 24095271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease in late-life dementia: a minor toxic consequence of devastating cerebrovascular dysfunction.
    Henry-Feugeas MC
    Med Hypotheses; 2008; 70(4):866-75. PubMed ID: 17825499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of aging in dementia: It is time to refocus attention on the main risk factor of dementia.
    Mecocci P; Boccardi V
    Ageing Res Rev; 2021 Jan; 65():101210. PubMed ID: 33186671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes.
    Infante-Garcia C; Ramos-Rodriguez JJ; Hierro-Bujalance C; Ortegon E; Pickett E; Jackson R; Hernandez-Pacho F; Spires-Jones T; Garcia-Alloza M
    Mol Neurobiol; 2018 Jul; 55(7):6130-6144. PubMed ID: 29224179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.